Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-012991

EVP & Chief Operating Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Friedl-Naderer Johanna EVP & Chief Operating Officer 2023-02-22 Grant or award +60,000 150,000 D
Derivatives
Friedl-Naderer Johanna EVP & Chief Operating Officer 2023-02-22 Grant or award · Stock Option (Right to Buy) +70,000 70,000 D
Loading xslF345X03/doc4.xml…